NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Hepatitis C treatment numbers fell sharply in 2020

By Mindo - 06th Apr 2021

The numbers of people who commenced curative direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) dropped sharply to 532 last year, compared to 1,196 in 2019.

A spokesperson for the HSE National Hepatitis C Treatment Programme (NHCTP) told the Medical Independent (MI) that treatment numbers had been affected by the Covid-19 pandemic.

“This is mainly due to the disruption of primary care and the reduction in outpatient numbers in hospital,” said a spokesperson. “However, the NHCTP has remained open since the start of the Covid-19 pandemic and new patients continued to be assessed and treated. There were some delays in receiving PCR and genotyping results in the early period of the pandemic, but these have been resolved and treatment numbers are now increasing.”

The NHCTP informed MI the target for 2021 “is to seek and treat as many as possible”.

Ireland has committed to the World Health Organisation HCV elimination targets by 2030. However, clinicians and community workers have warned that more efforts are required to ensure treatment access for the most difficult to reach patients. Most diagnosed cases are in people who currently, or formerly, injected drugs.

HCV can be asymptomatic or mildly symptomatic for many years.

Ms Nicola Perry, Manager at Community Response, which works extensively on improving HCV treatment access, said HCV elimination required a multifaceted, multidisciplinary approach based in community settings.

See news feature, Walking the hard road to HCV elimination – Medical Independent

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read